医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SuperECG: Mobile 24H ECG with Samsung G S4 – Analyze Your Heart Rhythm with Your Phone

2014年02月07日 PM05:55
このエントリーをはてなブックマークに追加


 

HELSINKI

SuperECG.com has tested its 24 h ECG analysis service with Samsung smartphones.

“It is now possible to do a proper 24 h ECG heart rhythm monitoring with a smartphone. We tested our HeartBug service with Samsung S4 and S2 phones and it works fine. It is therefore not necessary to own a PC for heart rhythm analysis”, says Mr Ossi Tiihonen, founder, SuperECG.com.

Video about the test is available here:

http://www.youtube.com/watch?v=ZSTRM5bSPrs

HeartBug starter kit comes with 24 h capable professional-grade ECG device (usually called a Holter monitor) and six automated analyses. Starter kit costs only 199 dollars and is available at the

SuperECG web shop, http://store.superecg.com/

and at

Amazon, http://www.amazon.com/HeartBug-Starter-Kit/dp/B00GXA1YDI .

More analyses can be purchased from the web shop, six analyses with electrodes costs only 39 dollars.

HeartBug device operates with a Micro-USB connection and the service can be used with any device with an internet connection and a USB port, like PC’s, smart phones with a USB Host feature etc. When connected to a USB host device the HeartBug acts just as a regular memory stick. There is no need to install special software. HeartBug device can be charged with regular cellphones chargers or PC USB ports.

For Press

SuperECG offers free HeartBug starter kits for first 50 media representatives. If you are interested in testing the HeartBug, send your contact information to superecg@superecg.com.

CONTACT

SuperECG
Ossi Tiihonen
Tel. +358 40 506 5547
Email superecg@superecg.com
http://www.superecg.com/en/press

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent
  • Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing